Pharyngeal Squamous Cell Carcinoma — Trials

Pharyngeal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

297 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 106
Recruiting: 52
Ph III recruiting: 3
Growth YoY: −15%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (51)

clinicaltrialsPublishedShowing 101–102 of 102 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00063895	Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck	completed	Phase 1 / Phase 2	80	National Cancer Institute (NCI)NIH	1	Jan 9, 2013	clinicaltrials
NCT01637194	Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer	completed	Phase 1	12	Fox Chase Cancer CenterOTHER	1	Jul 11, 2012